• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1831年至1980年瑞典血友病患者的预期寿命。

Life expectancy of Swedish haemophiliacs, 1831-1980.

作者信息

Larsson S A

出版信息

Br J Haematol. 1985 Apr;59(4):593-602. doi: 10.1111/j.1365-2141.1985.tb07353.x.

DOI:10.1111/j.1365-2141.1985.tb07353.x
PMID:3885998
Abstract

Life expectancy of Swedish haemophiliacs has been estimated for the period 1831-1980. The data were derived from 948 haemophiliacs of whom 580 survived throughout 1980. Applying standard demographic techniques, median life expectancy of patients with severe haemophilia was found to have increased fivefold, from a mere 11 years during the period 1831-1920 to 56.8 years during 1961-80. The corresponding estimates for patients with moderate haemophilia were 27.5 and 71.5 years, respectively. The limited data on patients with mild haemophilia did not indicate any significant improvements in mortality. From the beginning of this century to 1980 median life expectancy for Swedish males increased from 61.7 years to 75.6 years, an increase of 23%. Analysing the last 12 years of the study (1969-80), death rates for patients with severe haemophilia below the age of 45 were not much different from those of Swedish males in the population as a whole. The investigation implies that the mortality of haemophiliacs in Sweden is approaching that of the total male population.

摘要

瑞典血友病患者1831年至1980年期间的预期寿命已得到估算。数据来源于948名血友病患者,其中580人存活至1980年。运用标准人口统计学技术,发现重度血友病患者的中位预期寿命增长了五倍,从1831年至1920年期间的仅仅11岁增至1961年至1980年期间的56.8岁。中度血友病患者的相应估算值分别为27.5岁和71.5岁。轻度血友病患者的有限数据未显示死亡率有任何显著改善。从本世纪初到1980年,瑞典男性的中位预期寿命从61.7岁增至75.6岁,增长了23%。分析该研究的最后12年(1969年至1980年),45岁以下重度血友病患者的死亡率与瑞典男性总体人群的死亡率并无太大差异。该调查表明,瑞典血友病患者的死亡率正在接近男性总人口的死亡率。

相似文献

1
Life expectancy of Swedish haemophiliacs, 1831-1980.1831年至1980年瑞典血友病患者的预期寿命。
Br J Haematol. 1985 Apr;59(4):593-602. doi: 10.1111/j.1365-2141.1985.tb07353.x.
2
Hemophilia in Sweden. Studies on demography of hemophilia and surgery in hemophilia and von Willebrand's disease.瑞典的血友病。血友病及血友病和血管性血友病疾病的人口统计学与外科手术研究。
Acta Med Scand Suppl. 1984;684:1-72.
3
Life expectancy of Korean haemophiliacs, 1991-2012.1991 - 2012年韩国血友病患者的预期寿命
Haemophilia. 2014 Jul;20(4):e356-8. doi: 10.1111/hae.12475.
4
Trends in the epidemiology, diagnosed age and mortality rate of haemophiliacs in Taiwan: a population-based study, 1997-2009.台湾血友病患者的流行病学、诊断年龄及死亡率趋势:一项基于人群的研究,1997 - 2009年
Haemophilia. 2014 Jul;20(4):535-40. doi: 10.1111/hae.12373. Epub 2014 Jan 29.
5
Life expectancy and cause of death in individuals with haemophilia A and B in Norway, 1986-2018.1986-2018 年挪威甲型和乙型血友病患者的预期寿命和死亡原因。
Eur J Haematol. 2020 Nov;105(5):608-615. doi: 10.1111/ejh.13494. Epub 2020 Sep 1.
6
Haemophilia care in central Scotland 1980-94. I. Demographic characteristics, hospital admissions and causes of death.1980 - 1994年苏格兰中部的血友病护理。I. 人口统计学特征、住院情况及死因。
Haemophilia. 2000 Sep;6(5):494-503. doi: 10.1046/j.1365-2516.2000.00405.x.
7
Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930-79.1930年至1979年芬兰重度甲型血友病患者预期寿命的变化。
Br J Haematol. 1982 Sep;52(1):7-12. doi: 10.1111/j.1365-2141.1982.tb03856.x.
8
Epidemiology of haemophilia in Greece: an overview.希腊血友病流行病学概述
Thromb Haemost. 1994 Dec;72(6):808-13.
9
Mortality and causes of death in Italian persons with haemophilia, 1990-2007.意大利血友病患者 1990-2007 年的死亡率和死因。
Haemophilia. 2010 May;16(3):437-46. doi: 10.1111/j.1365-2516.2009.02188.x. Epub 2010 Feb 9.
10
Management of haemophilia in Sweden.瑞典血友病的管理
Thromb Haemost. 1976 Jun 30;35(3):510-21.

引用本文的文献

1
Hemophilia treatments and the paradox of choice.血友病的治疗与选择的悖论。
Res Pract Thromb Haemost. 2025 Mar 10;9(2):102726. doi: 10.1016/j.rpth.2025.102726. eCollection 2025 Feb.
2
Damoctocog Alfa Pegol for Hemophilia A Prophylaxis: An Italian Multicenter Survey.聚乙二醇化重组人凝血因子VIII用于A型血友病预防:一项意大利多中心调查。
Pharmaceuticals (Basel). 2023 Aug 22;16(9):1195. doi: 10.3390/ph16091195.
3
Cardiovascular Risk Scores among Asymptomatic Adults with Haemophilia.无症状血友病成人的心血管风险评分。
Arq Bras Cardiol. 2023 Sep 18;120(9):e20230004. doi: 10.36660/abc.20230004. eCollection 2023.
4
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia.为社区主导的遗传性出血性疾病国家研究蓝图奠定基础:优先研究重点以改变血友病患者的治疗模式。
Expert Rev Hematol. 2023 Mar;16(sup1):19-37. doi: 10.1080/17474086.2023.2171981.
5
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community.以患者为中心的药物警戒:遗传性出血性疾病群体的优先行动
Ther Adv Drug Saf. 2023 Feb 25;14:20420986221146418. doi: 10.1177/20420986221146418. eCollection 2023.
6
Cardiovascular disease in hereditary haemophilia: The challenges of longevity.遗传性血友病中的心血管疾病:长寿的挑战。
Br J Haematol. 2022 May;197(4):397-406. doi: 10.1111/bjh.18085. Epub 2022 Feb 21.
7
Low Bone Mineral Density in Hemophiliacs.血友病患者的低骨矿物质密度
Front Med (Lausanne). 2022 Feb 2;9:794456. doi: 10.3389/fmed.2022.794456. eCollection 2022.
8
Current Therapeutic Approach to Acute Myocardial Infarction in Patients with Congenital Hemophilia.先天性血友病患者急性心肌梗死的当前治疗方法
Life (Basel). 2021 Oct 11;11(10):1072. doi: 10.3390/life11101072.
9
Haemophilia.血友病。
Nat Rev Dis Primers. 2021 Jun 24;7(1):45. doi: 10.1038/s41572-021-00278-x.
10
Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972-2019.荷兰血友病患者的健康和治疗结果,1972-2019 年。
J Thromb Haemost. 2021 Oct;19(10):2394-2406. doi: 10.1111/jth.15424. Epub 2021 Jul 7.